Last update 08 May 2025

Neural stem cell therapy (Stemedica Cell Technologies)

Overview

Basic Info

Drug Type
Neural stem cell therapy
Synonyms
Ischaemiatolerant neural stem cells, Stemedyne NSC, itNSCs
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
Nervous System Diseases
Active Indication
Nervous System Diseases
Inactive Indication
Alzheimer DiseaseDiabetic RetinopathyParkinson Disease+ [2]
Originator Organization
Stemedica Cell Technologies, Inc.Stemedica Cell Technologies, Inc.
Active Organization
Stemedica Cell Technologies, Inc.Stemedica Cell Technologies, Inc.
Inactive Organization
Stanford University School of MedicineStanford University School of MedicineSwiss Federal Institute of TechnologySwiss Federal Institute of TechnologyFyodorov Eye Microsurgery Complex
+ [1]
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with Neural stem cell therapy (Stemedica Cell Technologies)
Login to view more data
100 Translational Medicine associated with Neural stem cell therapy (Stemedica Cell Technologies)
Login to view more data
100 Patents (Medical) associated with Neural stem cell therapy (Stemedica Cell Technologies)
Login to view more data
100 Deals associated with Neural stem cell therapy (Stemedica Cell Technologies)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Nervous System DiseasesPreclinical
United States
Stemedica Cell Technologies, Inc.Stemedica Cell Technologies, Inc.
01 Sep 2024
Alzheimer DiseasePreclinical
Switzerland
Swiss Federal Institute of TechnologySwiss Federal Institute of Technology
-
Diabetic RetinopathyPreclinical
Russia
Stemedica Cell Technologies, Inc.Stemedica Cell Technologies, Inc.
-
Diabetic RetinopathyPreclinical
Russia
Fyodorov Eye Microsurgery Complex
-
Parkinson DiseasePreclinical
Russia
Stemedica Cell Technologies, Inc.Stemedica Cell Technologies, Inc.
-
Spinal Cord InjuriesPreclinical
United States
Stanford University School of MedicineStanford University School of Medicine
-
StrokePreclinical
Mexico
NovastemNovastem
-
StrokePreclinical
Mexico
Stemedica Cell Technologies, Inc.Stemedica Cell Technologies, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free